Literature DB >> 10438523

Active site residues of human beta-glucuronidase. Evidence for Glu(540) as the nucleophile and Glu(451) as the acid-base residue.

M R Islam1, S Tomatsu, G N Shah, J H Grubb, S Jain, W S Sly.   

Abstract

Human beta-glucuronidase (hGUSB) is a member of family 2 glycosylhydrolases that cleaves beta-D-glucuronic acid residues from the nonreducing termini of glycosaminoglycans. Amino acid sequence and structural homology of hGUSB and Escherichia coli beta-galactosidase active sites led us to propose that residues Glu(451), Glu(540), and Tyr(504) in hGUSB are involved in catalysis, Glu(451) being the acid-base residue and Glu(540) the nucleophile. To test this hypothesis, we introduced mutations in these residues and determined their effects on enzymes expressed in COS cells and GUSB-deficient fibroblasts. The extremely low activity in cells expressing Glu(451), Glu(540), and Tyr(504) hGUSBs supported their roles in catalysis. For kinetic analysis, wild type and mutant enzymes were produced in baculovirus and purified to homogeneity by affinity chromatography. The k(cat)/K(m) values (mM(-1).s(-1)) of the E540A, E451A, and Y504A enzymes were 34,000-, 9100-, and 830-fold lower than that of wild type hGUSB, respectively. High concentrations of azide stimulated the activity of the E451A mutant enzyme, supporting the role of Glu(451) as the acid-base catalyst. We conclude that, like their homologues in E. coli beta-galactosidase, Glu(540) is the nucleophilic residue, Glu(451) the acid-base catalyst, and Tyr(504) is also important for catalysis, although its role is unclear. All three residues are located in the active site cavity previously determined by structural analysis of hGUSB.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438523     DOI: 10.1074/jbc.274.33.23451

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  MAP/ERK kinase kinase 1 (MEKK1) mediates transcriptional repression by interacting with polycystic kidney disease-1 (PKD1) promoter-bound p53 tumor suppressor protein.

Authors:  M Rafiq Islam; Tamara Jimenez; Christopher Pelham; Marianna Rodova; Sanjeev Puri; Brenda S Magenheimer; Robin L Maser; Christian Widmann; James P Calvet
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  Missense models [Gustm(E536A)Sly, Gustm(E536Q)Sly, and Gustm(L175F)Sly] of murine mucopolysaccharidosis type VII produced by targeted mutagenesis.

Authors:  Shunji Tomatsu; Koji O Orii; Carole Vogler; Jeffrey H Grubb; Elizabeth M Snella; Monica A Gutierrez; Tatiana Dieter; Kazuko Sukegawa; Tadao Orii; Naomi Kondo; William S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-28       Impact factor: 11.205

3.  Structure-based design, synthesis and biological evaluation of β-glucuronidase inhibitors.

Authors:  Khalid M Khan; Nida Ambreen; Muhammad Taha; Sobia A Halim; Shagufta Naureen; Saima Rasheed; Shahnaz Perveen; Sajjad Ali; Mohammad Iqbal Choudhary
Journal:  J Comput Aided Mol Des       Date:  2014-04-27       Impact factor: 3.686

4.  Active site mutant transgene confers tolerance to human beta-glucuronidase without affecting the phenotype of MPS VII mice.

Authors:  W S Sly; C Vogler; J H Grubb; M Zhou; J Jiang; X Y Zhou; S Tomatsu; Y Bi; E M Snella
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

5.  Identification and cloning of gusA, encoding a new beta-glucuronidase from Lactobacillus gasseri ADH.

Authors:  W M Russell; T R Klaenhammer
Journal:  Appl Environ Microbiol       Date:  2001-03       Impact factor: 4.792

6.  Production of MPS VII mouse (Gus(tm(hE540A x mE536A)Sly)) doubly tolerant to human and mouse beta-glucuronidase.

Authors:  Shunji Tomatsu; Koji O Orii; Carole Vogler; Jeffrey H Grubb; Elizabeth M Snella; Monica Gutierrez; Tatiana Dieter; Christopher C Holden; Kazuko Sukegawa; Tadao Orii; Naomi Kondo; William S Sly
Journal:  Hum Mol Genet       Date:  2003-05-01       Impact factor: 6.150

7.  Activity-based probes for functional interrogation of retaining β-glucuronidases.

Authors:  Liang Wu; Jianbing Jiang; Yi Jin; Wouter W Kallemeijn; Chi-Lin Kuo; Marta Artola; Wei Dai; Cas van Elk; Marco van Eijk; Gijsbert A van der Marel; Jeroen D C Codée; Bogdan I Florea; Johannes M F G Aerts; Herman S Overkleeft; Gideon J Davies
Journal:  Nat Chem Biol       Date:  2017-06-05       Impact factor: 15.040

8.  Development and application of novel constructs to score C:G-to-T:A transitions and homologous recombination in Arabidopsis.

Authors:  Gert Van der Auwera; Joke Baute; Melanie Bauwens; Ingrid Peck; Denis Piette; Michael Pycke; Pieter Asselman; Anna Depicker
Journal:  Plant Physiol       Date:  2007-10-05       Impact factor: 8.340

Review 9.  Mutations and polymorphisms in GUSB gene in mucopolysaccharidosis VII (Sly Syndrome).

Authors:  Shunji Tomatsu; Adriana M Montaño; Vu Chi Dung; Jeffrey H Grubb; William S Sly
Journal:  Hum Mutat       Date:  2009-04       Impact factor: 4.878

Review 10.  Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.

Authors:  Paul Awolade; Nosipho Cele; Nagaraju Kerru; Lalitha Gummidi; Ebenezer Oluwakemi; Parvesh Singh
Journal:  Eur J Med Chem       Date:  2019-12-04       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.